This recommendation is often stated in the Dutch national BCC guidelines (which are also followed by other countries, including Australia and the United States) and has major implications in the allocation of dermatologic care because of the enormous volume of skin cancer patients in predominantly white populations (most notably in Australia and the United States but also in Europe).